FDA Inspection 1103463 — Daniel E. Grosz, MD
The FDA completed an inspection of Daniel E. Grosz, MD on September 18, 2019 in Encino, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Encino, CA (United States)
Additional Details
Clinical Investigator (CI)